WillItSurvive
Insurance companies · United States

Aflac

Supplemental health and life insurer selling payroll-deduction policies in the US and Japan.

Hard to displace
Assessed 20 July 2026 · Evidence as of 20 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 20 July 2026 · Checkable from August 6, 2026 · Every call on the record Checkpoint: Q2 2026 earnings release and CFO update
The call

Aflac keeps its licensed insurance position and Japan cancer-claims data intact while earnings wobble and a large data breach works through litigation.

Aflac sells supplemental insurance to workers through their employers, mainly in the United States and Japan. It is hard to replace because insurance companies need government licenses, large amounts of cash reserves to pay claims, and long histories of reliable data to set prices, which new competitors and AI tools cannot quickly build. The biggest near-term risk is the cost of settling a data breach that affected 22.65 million people, plus whether the recent drop in revenue is temporary noise from Japan's currency or a sign that fewer people want to buy the product.

Why
01
AI pressure: None apparent. AI speeds up claims processing and call centers but cannot take on licensed insurance liability or capital reserves. Could AI do the core job? Unlikely.
02
Bigger players: MetLife. MetLife competes as a scale bundler for worksite benefits, pushing against Aflac's specialist payroll-deduction pitch. Could a giant copy it? No, they are blocked.
03
What protects it. State insurance licenses, capital reserves, decades of Japan cancer/health claims data, and payroll-deduction sales relationships with employers.
What would change this call
Size and timing of the 2025 data breach MDL settlement (22.65M affected, MD Georgia). Shows whether the breach liability stays manageable or forces reserve action.
Q2 2026 earnings on August 6, 2026 EPS versus $7.05 FY2026 estimate. A third straight miss would suggest structural weakening, not just noise.
Any public MetLife worksite RFP wins against Aflac reported in trade press. Would indicate actual share loss to the named rival rather than stable leadership.
Key numbers
  • FY2025 revenue $17.2B, down 9.3% YoY (2026-02-04)
  • Market cap about $63.5B (2026-07-20)
  • More than 50 million policyholders worldwide (2026-06-30)
Named risks
  • Data breach MDL covering 22.65M individuals could produce a large settlement or damages award. Severity: high
  • Bipartisan Senate inquiry (Cassidy, Hassan) could trigger further regulatory action on breach handling. Severity: medium
  • Two consecutive quarterly EPS misses (Q4 2025, Q1 2026) raise question of structural Japan segment slowdown. Severity: medium
  • Conflicting third-party revenue figures (aggregator vs company PR) create data reliability confusion for investors. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
MetLifecontestingCalled Aflac's most formidable global rival; Argus deal pushes into its core benefits turf, 2026-05-20
Unum Group (Colonial Life)contestingDirect worksite voluntary benefits competitor named alongside Aflac in 2026-05-20 Zacks industry outlook
Japan Post InsurancecontestingDomestic Japan incumbent competing with Aflac's cancer/medical insurance leadership, per 2026-07-13 analysis
Questions people ask
Is Aflac profitable in 2026?
Yes. Aflac posted FY2025 net earnings of $3.6 billion ($6.82 diluted EPS) on $17.2 billion revenue, and Q1 2026 revenue rose to $4.24 billion, though EPS of $1.75 missed the $1.80 consensus, per Aflac's Feb 4, 2026 release and July 2026 tracking.
Who owns Aflac?
Aflac Incorporated (NYSE: AFL) is publicly traded with no parent company. Its largest institutional shareholders as of March 13, 2026 are Japan Post Holdings (~9.3%) and Vanguard funds, per WSJ data; market cap stood near $63.5 billion on July 20, 2026.
How serious is the Aflac data breach?
Serious but survivable so far. The June 12, 2025 cyberattack affected roughly 22.65 million people, one of the largest US health data breaches reported that year, and is consolidated into an active multidistrict class action in Georgia federal court as of April 2026.
Who is Aflac's biggest competitor?
MetLife is described as Aflac's 'most formidable global rival,' competing on scale and bundled benefits rather than Aflac's specialist worksite pitch. Aflac's 2026 Argus dental/vision acquisition pushes further into MetLife's core benefits territory, per Zacks, May 2026.
Is Aflac's stock a good buy in 2026?
Aflac traded near $124.43 on July 20, 2026, close to its 52-week high of $125.93, with a ~$63.5 billion market cap. However, Dowling & Partners trimmed its FY2026 EPS estimate to $7.05 on July 15, 2026 after two consecutive quarterly misses.
Timeline
  • 2026-08-06Aflac scheduled to release Q2 2026 earnings and CFO video update
  • 2026-07-15Dowling and Partners trims Aflac FY2026 EPS estimate to $7.05
  • 2026-07-14Aflac Q1 2026 revenue reported at $4.24B, EPS $1.75 misses consensus
  • 2026-06-30Aflac states it protects more than 50 million people worldwide
  • 2026-04-27Data breach MDL consolidates roughly 30 lawsuits in M.D. Georgia
  • 2026-02-04Aflac reports FY2025 results: $17.2B revenue, $3.6B net earnings, raises dividend 5.2%
  • 2025-08Senators Cassidy and Hassan send inquiry letters over Aflac data breach
  • 2025-06-12Cyberattack occurs, later found to affect about 22.65 million individuals
  • 1955-11-17Aflac founded in Columbus, Georgia as American Family Life Insurance Company
Revision history
20 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources